| |
Recent News

October 5, 2012 :: |
CritiTech Announces Hire of New Vice President of Technical Operations
Press
Release
|
October 4, 2012 :: |
CritiTech
Names New Chief Operating Officer
Press
Release
|
July 12, 2012 :: |
CritiTech,
Inc.(USA) and Finoso Pharma Private Limited (India)
enthusiastically announce the formation of a joint venture,
FinoTech Pharma!
Press
Release |
April 15, 2012 :: |
CritiTech Founder,
Dr. Bala Subramaniam to present at International Symposium
on Supercritical Fluids in San Francisco, May 13-16. See
attached Abstract.
Jahna Howell, Director of Lab Operations at CritiTech,
to attend as well. |
April 13, 2012 :: |
Planting Saplings
in India - (click photos to enlarge) |

news archive |
|
|
|
|
CritiTech

CritiTech specializes in optimizing the delivery
of challenging drug substances-- potent molecules, poorly
soluble compounds and biomolecules. Using our proprietary
SCF Technology and our ability to simplify formulations we
can extend the potential delivery options to oral, injection,
inhalation routes as well as to implantable devices. We thus
provide the differentiated products that truly benefit patients
in all age groups from pediatric to geriatric. We develop
products with significant commercial potential both independently
and in collaboration with strategic partners.
Our New C-FPC-411 Crystallizer

Click here for more
|
|
|
Current Clinical Trials

Nanotax®
(Ovarian Cancer)
Quick Links
eNews
Downloads
Events
Video
Portal
Case Studies
CS
#106 (Fusion Inhibitor)
CS#107
(Natural Product)
>case
archive
|
|